ClinicalTrials.gg
CompletedNCT06263036Updated Jun 10, 2024

Morphometric Examination of the Larynx

An observational study in Laryngeal Dimensions in Males and Females, sponsored by Acibadem University. Completed. Per ClinicalTrials.gov, last updated 2024-06-10.

Sponsored by Acibadem University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
102
Sex
All
01

Study summary

Objective: To measure laryngeal dimensions in a sample of Turkish cadavers including males and females of various ages and heights.

Patients and Methods: Morphological measurement was performed on 102 laryngeal specimens. Laryngeal cartilages were collected from human cadavers. All dimensions of the cartilages were measured using a thread and vernier calipers. Age, sex, and height were recorded. Results for men and women were compared.

02

Conditions studied

  • Laryngeal Dimensions in Males and Females

Browse trials for

Keywords

  • larynx, measurement, cadaver, Turkish population
03

In context

Laryngeal Diseases

147 studies on the registry are indexed under Laryngeal Diseases; 26 are open to participants now.

This study's enrollment of 102 is below the median of 138 across 31 observational studies indexed under Laryngeal Diseases.

Browse Laryngeal Diseases studies →

Lead sponsor

Acibadem University is the lead sponsor of 222 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Probability sample

Study population

Turkish cadavers including males and females of various ages and heights

Eligibility criteria

Inclusion Criteria:human cadavers -

Exclusion Criteria:

-

05

Study design

Observational model
Other
Time perspective
Other
Enrollment
102 participants (actual)
Patient registry
No

Groups and cohorts

  • Men

    Cadavra

    Other: Men · Other: Women

  • Women

    Cadavra

    Other: Men · Other: Women

Interventions

  • OtherMen

    Laryngeal cartilages

  • OtherWomen

    Laryngeal cartilages

06

What researchers measure

Primary outcomes

  1. To measure laryngeal dimensions in cadavers

    To measure laryngeal dimensions in a sample of Turkish cadavers

    Time frame: 5 months

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2015 to primary completion in Jul 2015, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2024
First posted
Feb 16, 2024
StartActual
Feb 23, 2015
Primary completionActual
Jul 31, 2015
CompletionActual
Jul 31, 2015
Last update
Jun 10, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06263036
Responsible party
Sevgi Bilgen (Associate Professor, Acibadem University) — Principal investigator
First posted
Feb 16, 2024
Start date
Feb 23, 2015
Primary completion
Jul 31, 2015
Completion
Jul 31, 2015
Last update
Jun 10, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion